复方丹参滴丸治疗冠心病不稳定型心绞痛临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4

基金项目:


Clinical Study on Compound Danshen Dripping Pills for Unstable Angina Pectoris of Coronary Heart Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察复方丹参滴丸治疗冠心病不稳定型心绞痛的临床疗效及其对患者血脂水平、心功能的 影响。方法:将70 例冠心病不稳定型心绞痛患者随机分为常规组和联合组,常规组予以西医常规治疗,联合 组在西医常规治疗的基础上予以复方丹参滴丸治疗,共治疗2 个疗程。比较2 组治疗前后心功能、血脂水平, 并比较2 组临床疗效、不良反应。结果:联合组总有效率94.29%,高于常规组77.14% (P<0.05)。治疗前, 2 组左室射血分数(LVEF)、左室舒张末期内径(LVEDD)、左房室舒张早期血流峰值与舒张晚期血流峰值之 比(E/A) 比较,差异无统计学意义(P>0.05);治疗后,2 组LVEF、E/A 均升高(P<0.05),LVEDD 均下 降(P<0.05),且联合组LVEF、E/A 高于常规组(P<0.05),LVEDD 低于常规组(P<0.05)。治疗前,2 组 甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C) 水平比 较,差异无统计学意义(P>0.05);治疗后,2 组TG、LDL-C、TC 水平均降低(P<0.05),HDL-C 水平均升 高(P<0.05),且联合组TG、LDL-C、TC 水平低于常规组(P<0.05),HDL-C 水平高于常规组(P<0.05)。 常规组不良反应总发生率11.43%,联合组不良反应总发生率14.29%,2 组比较,差异无统计学意义(P> 0.05)。结论:复方丹参滴丸联合西医常规治疗可提高冠心病不稳定型心绞痛患者的临床疗效,改善心脏功 能,并可降低血脂水平,且不增加不良反应。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Compound Danshen Dripping Pills on unstable angina pectoris of coronary heart disease and its influence on blood lipid levels and the heart function of patients. Methods: A total of 70 patients with unstable angina pectoris of coronary heart disease were randomly divided into the conventional group and the combination group. The conventional group was treated with conventional western medicine, and the combination group was additionally treated with Compound Danshen Dripping Pills based on the conventional treatment. Both groups were treated for two courses. The heart function and blood lipid levels were compared between the two groups before and after treatment,and the clinical effects and adverse reactions were also compared. Results:The total effective rate was 94.29% in the combination group,higher than that of 77.14% in the conventional group (P<0.05). Before treatment, there was no significant difference in the left ventricular ejection fraction (LVEF), left ventricular end- diastolic diameter (LVEDD), and the ratio of left atrioventricular peak blood flow in early diastolic period to late diastolic period (E/A) between the two groups (P>0.05). After treatment,the levels of LVEF and E/A were increased (P<0.05),and the LVEDD levels were decreased (P<0.05);the levels of LVEF and E/A in the combination group were higher than those in the conventional group (P<0.05),and the LVEDD level was lower than that in the conventional group (P<0.05). Before treatment, there was no significant difference in the levels of triglyceride (TG),low- density lipoprotein cholesterol (LDL- C),total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) between the two groups (P>0.05). After treatment, the levels of TG, LDL- C and TC were decreased (P<0.05), and the HDL- C level was increased (P<0.05);the levels of TG,LDL-C and TC in the combination group were lower than those in the conventional group (P<0.05),and the HDL-C level was higher than that in the conventional group (P< 0.05). The total incidence of adverse reactions was 11.43% in the conventional group and 14.29% in the combination group,there being no significant difference between the two groups (P>0.05). Conclusion: The therapy of Compound Danshen Dripping Pills combined with conventional western medicine can improve the clinical effect on patients with unstable angina pectoris of coronary heart disease. It could enhance the heart function,and reduce the blood lipid levels without increasing adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

周锴,杨以勒,胡黄.复方丹参滴丸治疗冠心病不稳定型心绞痛临床研究[J].新中医,2023,55(7):80-84

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-12
  • 出版日期: